Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 16 studies | 30% ± 14% | |
peripheral blood | 16 studies | 35% ± 8% | |
intestine | 10 studies | 29% ± 13% | |
brain | 10 studies | 27% ± 9% | |
kidney | 8 studies | 25% ± 6% | |
liver | 6 studies | 33% ± 16% | |
bone marrow | 4 studies | 31% ± 8% | |
eye | 4 studies | 21% ± 3% | |
heart | 4 studies | 23% ± 4% | |
uterus | 4 studies | 33% ± 12% | |
lymph node | 4 studies | 33% ± 14% | |
breast | 4 studies | 24% ± 3% | |
adipose | 4 studies | 26% ± 10% | |
pancreas | 3 studies | 43% ± 13% | |
placenta | 3 studies | 28% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 13672.20 | 1445 / 1445 | 100% | 136.00 | 183 / 183 |
kidney | 100% | 12580.84 | 89 / 89 | 100% | 235.84 | 901 / 901 |
prostate | 100% | 9181.93 | 245 / 245 | 100% | 187.86 | 502 / 502 |
skin | 100% | 13482.52 | 1809 / 1809 | 100% | 217.46 | 472 / 472 |
stomach | 100% | 10745.35 | 359 / 359 | 100% | 154.35 | 286 / 286 |
breast | 100% | 14181.72 | 459 / 459 | 100% | 191.71 | 1117 / 1118 |
lung | 100% | 10128.67 | 577 / 578 | 100% | 151.68 | 1155 / 1155 |
intestine | 100% | 14121.36 | 966 / 966 | 100% | 170.91 | 526 / 527 |
uterus | 100% | 9645.41 | 170 / 170 | 100% | 166.93 | 458 / 459 |
ovary | 100% | 10757.92 | 180 / 180 | 100% | 126.34 | 429 / 430 |
pancreas | 100% | 8150.05 | 327 / 328 | 100% | 156.51 | 178 / 178 |
thymus | 100% | 9384.85 | 652 / 653 | 100% | 165.71 | 604 / 605 |
liver | 100% | 12056.72 | 225 / 226 | 100% | 194.71 | 406 / 406 |
bladder | 100% | 11457.86 | 21 / 21 | 99% | 172.38 | 501 / 504 |
brain | 99% | 7011.66 | 2625 / 2642 | 100% | 199.01 | 705 / 705 |
adrenal gland | 100% | 17662.53 | 258 / 258 | 99% | 152.27 | 228 / 230 |
adipose | 100% | 15069.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 221.34 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 209.33 | 29 / 29 |
muscle | 100% | 40974.28 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 9807.90 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 167.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 65.56 | 1 / 1 |
blood vessel | 100% | 10279.02 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 10277.80 | 913 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 25208.95 | 845 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032868 | Biological process | response to insulin |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0009410 | Biological process | response to xenobiotic stimulus |
GO_0035965 | Biological process | cardiolipin acyl-chain remodeling |
GO_0016507 | Cellular component | mitochondrial fatty acid beta-oxidation multienzyme complex |
GO_0042645 | Cellular component | mitochondrial nucleoid |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0003857 | Molecular function | 3-hydroxyacyl-CoA dehydrogenase activity |
GO_0003985 | Molecular function | acetyl-CoA C-acetyltransferase activity |
GO_0070403 | Molecular function | NAD+ binding |
GO_0004300 | Molecular function | enoyl-CoA hydratase activity |
GO_0000062 | Molecular function | fatty-acyl-CoA binding |
GO_0016509 | Molecular function | long-chain-3-hydroxyacyl-CoA dehydrogenase activity |
GO_0005515 | Molecular function | protein binding |
GO_0018812 | Molecular function | 3-hydroxyacyl-CoA dehydratase activity |
Gene name | HADHA |
Protein name | Hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha Trifunctional enzyme subunit alpha, mitochondrial (78 kDa gastrin-binding protein) (Monolysocardiolipin acyltransferase) (EC 2.3.1.-) (TP-alpha) [Includes: Long-chain enoyl-CoA hydratase (EC 4.2.1.17); Long chain 3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.211)] enoyl-CoA hydratase (EC 4.2.1.17) |
Synonyms | HADH |
Description | FUNCTION: Mitochondrial trifunctional enzyme catalyzes the last three of the four reactions of the mitochondrial beta-oxidation pathway . The mitochondrial beta-oxidation pathway is the major energy-producing process in tissues and is performed through four consecutive reactions breaking down fatty acids into acetyl-CoA . Among the enzymes involved in this pathway, the trifunctional enzyme exhibits specificity for long-chain fatty acids . Mitochondrial trifunctional enzyme is a heterotetrameric complex composed of two proteins, the trifunctional enzyme subunit alpha/HADHA described here carries the 2,3-enoyl-CoA hydratase and the 3-hydroxyacyl-CoA dehydrogenase activities while the trifunctional enzyme subunit beta/HADHB bears the 3-ketoacyl-CoA thiolase activity . Independently of the subunit beta, the trifunctional enzyme subunit alpha/HADHA also has a monolysocardiolipin acyltransferase activity . It acylates monolysocardiolipin into cardiolipin, a major mitochondrial membrane phospholipid which plays a key role in apoptosis and supports mitochondrial respiratory chain complexes in the generation of ATP . Allows the acylation of monolysocardiolipin with different acyl-CoA substrates including oleoyl-CoA for which it displays the highest activity . . |
Accessions | A0A2R8Y688 P40939 ENST00000643233.1 ENST00000643057.1 ENST00000645274.1 A0A2R8Y4E0 A0A2R8Y4F5 ENST00000492433.2 ENST00000643063.1 A0A2R8YDM1 ENST00000644428.1 H0YFD6 ENST00000646031.1 A0A2R8YG21 ENST00000646483.1 [P40939-2] ENST00000380649.8 [P40939-1] |